Regeneron Pharmaceuticals Inc - REGN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Regeneron Pharmaceuticals Inc - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
REGN	Nasdaq	8731	http://www.regeneron.com/	231.38 -11.38
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Regeneron Pharmaceuticals Inc 3 Stocks Dragging The Drugs Industry Downward - Jun 19th, 2013 11:03 am Today's 3 Best Stocks - Jun 18th, 2013 3:17 pm Stocks Up Ahead Of Fed; Proto Labs Breaks Out - Jun 18th, 2013 2:21 pm Top Treatments for High Cholesterol - Jun 18th, 2013 10:26 am 5 Undervalued Stocks Flying Under The Radar! - Jun 18th, 2013 10:25 am Biotechs Lose Ground As Achillion Takes a Dive - Jun 15th, 2013 11:16 am Is This Eye Drug Worth The Hype? - Jun 15th, 2013 8:56 am Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Laggard - Jun 14th, 2013 3:01 pm Valeant Biting More Than it Can Chew - Jun 14th, 2013 8:32 am Stocks Stage Huge Comeback; Myriad Turns Tail - Jun 13th, 2013 2:23 pm Stocks Gain, Hold Near Highs: MasterCard Finds Support - Jun 13th, 2013 11:28 am A Growth Investor Who Smartly Balances Blue Chips And Biotech - Jun 13th, 2013 10:30 am Does This Pipeline Promise Tomorrow's Blockbuster Sales? - Jun 12th, 2013 12:20 pm Biogen Stock Dips On Concerns Of MS Drug Protection - Jun 12th, 2013 11:38 am The First Real Cure in the $25 billion Asthma Market? - Jun 12th, 2013 9:10 am Zacks Investment Ideas feature highlights: Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, Regeneron, Celgene and First Trust Amex Biotechnology Index Fund - Jun 12th, 2013 4:15 am Regeneron Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 08:40 AM - Jun 11th, 2013 1:10 pm Opko: More Hidden Value In Partnerships, Equity Investments - Jun 10th, 2013 1:49 pm 5 Drugs Stocks Dragging The Industry Down - Jun 10th, 2013 11:03 am 5 Stocks To Watch Closely This Week - Jun 10th, 2013 8:09 am View All Current Headlines >>